CTRP9 acts via Adipo R1 receptors stimulating NO production in endothelial cells and endothelial dependent vasodilatation CTRP9 reduces endothelial inflammation and oxidative damage using the AdipoR1/AMPK activation pathway [57]. Here, C1QTNF9 is linked to inflammatory response.